




Scandinavian Journal of Surgery
2018, Vol. 107(2) 180 –186 
© The Finnish Surgical Society 2018
Reprints and permissions:  
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/145749 1 748220
journals.sagepub.com/home/sjs
IntraoperatIve ComplICatIons and mId-term  
Follow-Up oF large-dIameter Head metal-on-metal total 
HIp artHroplasty and HIp resUrFaCIng artHroplasty
s. s. a. miettinen1, t. J. mäkinen2, K. mäkelä3, H. Huhtala4,  
J. s. Kettunen1, v. remes2,5
1 Department of Orthopedics, Traumatology, and Hand Surgery, Kuopio University Hospital, Kuopio, 
Finland 
2 Department of Orthopedics and Traumatology, Helsinki University Hospital, Helsinki, Finland 
3 Department of Orthopedics and Traumatology, Turku University Hospital, Turku, Finland 
4 School of Health Sciences, University of Tampere, Tampere, Finland 
5 Pihlajalinna Oy, Helsinki, Finland
abstraCt
Background and Aims: large-diameter head total hip arthroplasty and hip resurfacing 
arthroplasty were popular in Finland from 2000 to 2012 for the treatment of hip 
osteoarthritis. the aim of this retrospective study was to investigate the mid-term 
survival of large-diameter head total hip arthroplasty patients operated on in three 
university hospitals and to compare these results to the survival of hip resurfacing 
arthroplasty patients.
Material and Methods: a total of 3860 hip arthroplasties (3029 large-diameter head total 
hip arthroplasties in 2734 patients and 831 hip resurfacing arthroplasties in 757 patients) 
were operated on between January 2004 and december 2009. the mean follow-up was 
4.3 years (range: 0.3–8.0 years) in the total hip arthroplasty group and 5.1 years (range: 
1.7–7.9 years) in the hip resurfacing arthroplasty group. Cox multiple regression model 
and Kaplan–meier survival analysis were used to study the survival of the total hip 
arthroplasties and the hip resurfacing arthroplasties. Intraoperative complications and 
reasons for revisions were also evaluated.
Results: In Cox regression analysis, the hazard ratio for revision of hip resurfacing 
arthroplasty was 1.5 compared with large-diameter head total hip arthroplasty (95% 
confidence interval: 1.0–2.2) (p = 0.029). the cumulative Kaplan–meier survival rate was 
90.7% at 7.7 years for the large-diameter head total hip arthroplasty (95% confidence 
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interval: 86.8–94.6) and 92.2% at 7.6 years for hip resurfacing arthroplasty (95% confidence 
interval: 89.9–94.6). there were a total of 166/3029 (5.5%) intraoperative complications in the 
large-diameter head total hip arthroplasty group and 20/831 (2.4%) in the hip resurfacing 
arthroplasty group (p = 0.001). revision for any reason was performed on 137/3029 (4.5%) 
of the arthroplasties in the large-diameter head total hip arthroplasty group and 52/831 
(6.3%) in the hip resurfacing arthroplasty group (p = 0.04).
Conclusion: the mid-term survival of both of these devices was poor, and revisions due 
to adverse reactions to metal debris will most likely rise at longer follow-up. there were 
more intraoperative complications in the large-diameter head total hip arthroplasty group 
than in the hip resurfacing arthroplasty group.
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InTRODUCTIOn
Large-diameter head (LDH) metal-on-metal (MoM) 
total hip arthroplasty (THA) and hip resurfacing 
arthroplasty (HRA) became widely accepted alterna-
tives to conventional metal-polyethylene bearing 
THA in the late 1990s for the treatment of hip osteo-
arthritis (OA) (1–3). One reason for the increased use 
of LDH THA and HRA was the modest long-term 
results associated with the metal-on-polyethylene 
bearing due to wear and osteolysis, especially among 
young and active people. Other reason for the popu-
larity of LDH THA and HRA was based on the sup-
posed increased functional ability as a consequence 
of the larger head size compared to smaller head size 
used in conventional THA. The number of LDH THA 
and HRA increased rapidly in the late 2000s and rep-
resented approximately 10% of all implanted hip 
devices (4). HRA offers several potential advantages 
over LDH THAs including preservation of own prox-
imal femur, reduced risk of dislocation, retaining hip 
anatomical biomechanics, and easy revision to THA 
if needed (5). Intraoperative and post-operative com-
plication profiles and revision rates of LDH THAs is 
different than HRAs based on implant surgery tech-
nique, implant design, and patient selection (5, 6).
After widespread use, it soon became obvious that 
there are specific problems related to MoM bearings, 
like periarticular fluid collections and even soft-tis-
sue masses or gluteal muscle necrosis (5, 7). These 
findings were termed adverse reactions to metal 
debris (ARMeD). The British Orthopedic Association 
issued in April 2010 a statement to halt the use of 
MoM bearing surfaces (8). This was followed by a 
statement by the Finnish Arthroplasty Association in 
June 2012 not to use LDH THA or HRA (9). Despite 
these recommendations, some centers have still 
elected to use MoM bearings in selected patient 
groups.
The aim of this study was to investigate mid-term 
survival of LDH THA and HRA. In addition, intraop-
erative and early complications of these devices were 
evaluated. Our hypotheses were that LDH THAs have 
more intraoperative complications and also higher 
risk of revisions than HRAs do.
MATERIAL AnD METHODS
STUDy DESIgn
This is a retrospective, multicenter study. The partici-
pating university hospitals were Helsinki University 
Hospital, Kuopio University Hospital, and Turku 
University Hospital. Primary outcome of this study 
was survival rate comparison of LDH THAs over 
HRAs. Secondary outcome was comparison of com-
plication and revision rates between LDH THA and 
HRA.
PATIEnTS
A total of 3860 hip arthroplasties in 3491 patients were 
performed between January 2004 and December 2009. 
There were 3029 stemmed THAs in 2734 patients and 
831 HRAs in 757 patients. Of these hips, 2103 were 
males (54.5%) and 1757 females (45.6%). Among the 
patients, there were more males in both groups. In the 
HRA group, there were 570/831 (68.6%) males, and in 
the THA group, there were 1610/3208 (50.2%) males. 
The mean follow-up of study patients was 4.4 (range: 
0.3–8.0 years) years. In the THA group, follow-up was 
4.3 years (range: 0.3–8.0 years), and in the HRA group, 
5.1 years (range: 1.7–7.9 years; standard deviation 
(SD) 5.1).
Demographic data (age, gender, side, indication 
for surgery, date of surgery) and surgical details (sur-
gical approach, intraoperative complication, type, 
and name of components used) were collected from 
the medical records (Table 1 and Appendix 1). There 
were 16 different THA femoral components, 14 differ-
ent THA acetabular components, and 6 different 
HRAs (Appendix 1). THAs and HRAs were per-
formed according to the manufacturers’ instructions. 
Reasons for revision were evaluated, and the revision 
risk of LDH MoM THA was compared to revision risk 
of HRA.
THAs with a head size of 38 mm or larger were 
included to this study, and THAs with smaller head 
sizes were excluded. The rationale for this selection 
was to standardize the effect of head size on the sur-
vival analysis of LDH THAs and HRAs.
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RADIOLOgICAL AnALySIS
Radiological assessments were conducted from the 
anteroposterior (AP) full-weight-bearing and true-
lateral post-operative radiographs. Anteversion and 
inclination angles of the acetabular component were 
measured according to the method described by 
Widmer (10). Picture archiving and communication 
systems (PACS) were used in every participating 
hospital. AgFA IMPAX (ver. 6.5.2.657) PACS was 
used at Helsinki University Hospital, and Sectra 
Workstation IDS7 (ver.15.1.8.5) PACS were used at 
Kuopio University Hospital and Turku University 
Hospital.
STATISTICAL AnALySIS
Kaplan–Meier analysis was used to study implant 
survival. The outcome was any revision surgery, 
defined as removal or exchange of at least one of the 
prosthetic components. A Cox multiple regression 
model was used to assess revision risk (hazard ratio 
(HR)) with a 95% confidence interval (CI) and with 
adjustment hazard ratio (aHR) for age at surgery, 
gender, operated side, and diagnosis. Comparison of 
continuous data was carried out using a Mann–
Whitney U-test. For categorical data, a chi-square test 
was used. A dot plot chart was used to evaluate the 
cup positioning of the revised components (antever-
sion and inclination angles). All p values ≤0.05 were 
considered statistically significant. All data were 
analyzed using SPSS (SPSS Inc., Chicago, IL, USA. 
Ver. 21.0.0, IBM).
RESULTS
The cumulative Kaplan–Meier survival rate was 90.7% 
at 7.7 years for LDH THA (95% CI: 86.8–94.6) and 
92.2% at 7.6 years for HRA (95% CI: 89.9–94.6) 
(p = 0.210) (Fig. 1).
Mean time to revision was 1.2 years (range, 1 day–
7.4 years) in the THA group and 1.9 years (range, 
1 day–6.5 years) in the HRA group (p = 0.004). Revision 
for any reason was performed for 137/3029 (4.5%) 
hips in the THA group and for 52/831 (6.3%) hips in 
the HRA group (p = 0.040) (Table 2). There was a trend 
towards a higher incidence of periprosthetic fractures 
and component loosening in the HRA group com-
pared with the THA group even though there was no 
statistically significant difference between the groups 
(p = 0.078). ARMeD was a reason for revision in the 
THA group for 17/3029 (0.6%) hips and in the HRA 
group for 3/831 (0.4%) hips (p = 0.078). However, if 
revisions due to ARMeD were excluded, revision was 
performed for 120/3012 (4.0%) hips in the THA group 
and for 49/828 (5.9%) hips in the HRA group (p = 0.016). 
Revisions were performed for 78/1496 (5.7%) females 
in the THA group and for 23/261 (8.8%) females in the 
HRA group, whereas in the THA and HRA groups, 
males had 59/1533 (3.8%) and 29/570 (5.1%) revisions, 
respectively. Overall, females had more revisions 
(5.7%) than males (4.2%) (p = 0.025).
In the LDH THA group, there were 166/3029 (5.5%) 
intraoperative complications, whereas in the HRA 
group there was a total of 20/831 (2.4%) complications 
(p = 0.001) (Table 3). The most common intraoperative 
complication in the LDH THA group was femoral 
fracture at the calcar region (3.5%) and in the HRA 
group, it was nerve damage (1.3%) (p = 0.001) (Table 3).
In the multivariable Cox regression model adjusted 
for age, sex, operation side, and operation diagnosis, 
HRA (aHR = 1.5 (95% CI: 1.0–2.2), p = 0.029) and female 
sex (aHR = 1.5 (95% CI: 1.1–2.0), p = 0.009) were associ-
ated with a higher risk of revision. The only significant 
operation diagnosis was fracture (aHR = 1.8 (95% CI: 
1.1–3.1), p = 0.023) compared with primary OA. Age 
(aHR = 1.0) was not associated with risk of revision.
TABLE 1
Baseline demographic data.
HRA THA p value
 n (%) n (%)  
number of 
arthroplasties
831 (21.5) 3029 (78.5)  
Sex <0.001
 Male 570 (68.6) 1533 (50.6)  
 Female 261 (31.4) 1496 (49.4)  
Operation indication <0.001
 Primary osteoarthritis 703 (84.6) 2188 (72.2)  
  Developmental 
dysplasia of the hip
90 (10.8) 262 (8.6)  
  Fracture (acute or 
sequelae of the hip)
14 (1.7) 193 (6.4)  
 Rheumatoid arthritis 12 (1.4) 93 (3.1)  
 Avascular necrosis 8 (1.0) 192 (6.3)  
 Other 4 (0.5) 101 (3.3)  
Operation side  0.996
 Left 385 (46.3) 1626 (53.7)  
 Right 446 (53.7) 1403 (46.3)  
Surgical approach <0.001
 Posterolateral 751 (90.4) 1585 (52.3)  
 Lateral (Hardinge) 78 (9.4) 1443 (47.6)  
 Anterior 2 (0.2) 1 (0.1)  
HRA: hip resurfacing arthroplasty; THA: total hip arthroplasty.
Fig. 1. The cumulative Kaplan–Meier survival rate was 90.7% at 
7.7 years for LDH THA (95% CI: 86.8–94.6) and 92.2% at 7.6 years 
for HRA (95% CI: 89.9–94.6) (p = 0.210). THA: total hip arthroplasty; 
HRA: hip resurfacing arthroplasty.
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Specific brands of LDH THAs and HRAs were 
compared to determine whether there was any differ-
ence between the components in terms of the risk of 
having intraoperative complications or revision; there 
were no statistically significant differences between 
the components in either group (Appendix 1).
In the radiological analyses, the anteversion and 
inclination angles of the acetabular component were 
measured. In the THA group, mean anteversion angle 
was 20.8° (SD: 11.2, range: –35.0 to 60.0) and mean 
inclination was 44.6° (SD: 8.1, range: –17.0 to 91.0). In 
the HRA group, mean anteversion of the acetabular 
component was 19.6° (SD: 11.1, range: –29.4 to 59.0) 
and mean inclination was 45.4° (SD: 8.6, range: 5.0–
93.0). There were statistically significant differences in 
the radiological measurements of the revised THA 
compared with non-revised THA patients. Mean ante-
version angle of the acetabular component of the 
revised patients was lower (17.6°, range: –35.0 to 59.0; 
p = 0.001) and inclination angle was higher (47.8°, 
range: –17.0 to 93.0; p = 0.001). Dispersion of survived 
and revised acetabular component inclination and 
anteversion angles are shown in the dot plot (Fig. 2).
DISCUSSIOn
This study explored the mid-term survival of LDH 
THA and HRA. Intraoperative and early complica-
tions were also evaluated. The results showed that 
HRAs had 1.5 times higher HR for revision than 
LDH THAs. More intraoperative complications were 
noted in the LDH THA group compared to the HRA 
group.
The use of modular LDH THAs and HRAs with 
MoM bearings became very popular in 1990s and 
early years of 2000s (1–4). Short- and mid-term results 
of LDH MoM bearings were excellent, and the 
increased jumping distance from the large head gave 
inherent stability of the articulation (11, 12). However, 
studies with longer follow-up have shown high fail-
ure rates of MoM bearing THAs (13–17). Although 
both LDH THA and HRA have large head size MoM 
bearing, LDH THAs have had higher revision rates 
due ARMED, and this is probably caused by corrosion 
at the taper junction (18). In a recent register study by 
Junnila et  al., short-term revision risk of LDH THA 
was not increased compared to analogous HRA in two 
of three studied device (Synergy/BHR THA vs BHR 
HRA and Bimetric/ReCap THA vs ReCap HRA). 
However, HRA had higher risk of revision in one of 
three devices (Corail and Summit/ASR THA vs ASR 
HRA) they studied (6).
TABLE 2
Demographic data of revision surgeries.
HRA THA p value
 n (%) n (%)  
Revision 0.040
 no 779 (93.7) 2892 (95.5)  
 yes 52 (6.3) 137 (4.5)  
 Reason for revision 0.078
  Periprosthetic fracture 14 (1.7) 36 (1.2)  
   Acetabular component 
loosening
11 (1.3) 28 (0.9)  
   Femoral component 
loosening
7 (0.8) 18 (0.6)  
  Infection 5 (0.6) 17 (0.6)  
  ARMeD 3 (0.4) 17 (0.6)  
  Component malposition 5 (0.6) 9 (0.3)  
  Dislocation 1 (0.1) 5 (0.2)  
   Acetabular component 
penetration through 
acetabulum
0 (0.0) 3 (0.1)  
  Component breakage 0 (0.0) 2 (0.1)  
  Component mismatch 0 (0.0) 1 (0.0)  
  Other 6 (0.7) 1 (0.0)  
HRA: hip resurfacing arthroplasty; THA: total hip arthroplasty; 
ARMeD: adverse reactions to metal debris.
TABLE 3
Intraoperative complication data.
HRA THA p value
 n (%) n (%)  
Intraoperative complication <0.001
 no 811 (97.6) 2863 (94.5)  
 yes 20 (2.4) 166 (5.5)  
  Reason for intraoperative 
complication
<0.001
  Fracture 1 (0.1) 139 (4.6)  
   Calcar fracture 0 (0.0) 105 (3.5)  
   greater trochanter fracture 0 (0.0) 25 (0.8)  
   Femur diaphysis fracture 0 (0.0) 0 (0.0)  
   Acetabulum fracture 1 (0.1) 9 (0.3)  
  nerve damage 11 (1.3) 18 (0.6)  
   Sciantic nerve 11 (1.3) 18 (0.6)  
   Other nerve damage 1 (0.1) 2 (0.1)  
   Insuffient fixation of 
acetabulum component
1 (0.1) 3 (0.1)  
  Vascular injury 1 (0.1) 1 (0.0)  
  Other 6 (0.7) 5 (0.2)  
Fig. 2. Dot plot showing anteversion and inclination angles of all 
acetabular components (n = 3860) measured from the 3-month 
follow-up radiographs.
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The spectrum of the intraoperative complication is 
different in HRAs compared to THAs. Common rea-
sons for failure and high revision rate are mechanical 
failures, such as femoral neck fracture in the HRAs 
and bearing-related problems such as soft-tissue reac-
tions and osteolysis (19, 20). In LDH THA group, the 
incidence of the calcar fracture was 3.5% which is sim-
ilar to previous studies where the incidence has been 
varied between 0.4% and 5.4% (21, 22). In our study, 
there were significantly more intraoperative femoral 
fractures in LDH THA group compared to HRA group. 
The reason for this is the difference in the surgical 
technique. When implanting the HRA, femoral com-
ponent is cemented on the femoral head. When 
implanting the conventional THA, the femoral canal is 
broached, and stem is implanted using press-fit con-
cept. There were two times more nerve injuries in 
HRA group compared to LDH THA group. In a previ-
ous study, incidence of nerve injury after HRA was 
0.5%, which is smaller than our findings showed 
1.3% (23). nerve injury is most likely related to the 
more demanding acetabular exposure as the femoral 
neck is not osteotomized, thus increasing the suscepti-
bility of stretching of the sciantic nerve. One major 
reason for THAs higher intraoperative complication 
rate is more heterogeneous operative indications com-
pared to HRAs.
The revision rate was higher in the HRA group 
(6.3%) than in the THA group (4.5%). Our mid-term 
revision rates are comparable to those of previous 
studies in which the prevalence of revision for any 
reason varied from 1.7% to 4.1% (23, 24). In a recent 
study based on data from the nordic Arthroplasty 
register at 6-year follow-up, the risk rate of revision 
for any reason was 1.5 times higher for MoM bearings 
compared with metal-on-polyethylene bearings (15). 
ARMeD has been the most common reason for revi-
sion of LDH MoM THA and HRA at 8-year follow-up 
in Australia and also in other studies with smaller 
sample sizes (4, 13–17). In our study, the most com-
mon reason for revision in the THA group was 
periprosthetic fracture (1.2%). The number of peripros-
thetic fractures was comparable between ours and 
other previous studies in which the incidence of post-
operative fracture varied between 0.07% and 18% (23, 
25). In our study, the second most common reason for 
revision was aseptic loosening either component 
(1.7%). Our results are similar to those of the nordic 
Arthroplasty Register Association (nARA) study, in 
which aseptic loosening was the reason for revision in 
1.9% of cases (15).
Fracture of the femoral neck was the most common 
reason for revision in the HRA group, with a preva-
lence of 1.7%. In previous studies, the prevalence of 
femoral neck fracture varied from 0.96% to 1.98% (5, 
19, 23). In general, revisions in both groups were per-
formed more often on females than on males. 
Previously, it has been shown that female gender is a 
risk factor for early revision in MoM arthroplasties 
(24). The specific component brand had no effect on 
the risk of revision or intraoperative complication in 
the THA or the HRA group (Appendix 1).
In the radiological analysis, we noticed that revised 
THAs and HRAs had smaller anteversion angles and 
larger inclination angles than survived THAs and 
HRAs. Previously, it was shown that component ori-
entation is important to ensure optimal survivorship 
of THA patients, and our results support this finding 
(1). Measurements of the anteversion and inclination 
angles include all studied components, as well as early 
loosened acetabular components, which causes dis-
persion of the results and can be seen in the dot plot 
chart (Fig. 2). Acetabulum component malposition is a 
factor that contributes to a higher dislocation rate, 
edge loading, excessive metal surface wear, and pseu-
dotumors (5, 26). Increased inclination and antever-
sion angles have also been shown to correlate with 
higher serum metal ion levels following MoM arthro-
plasties (5, 16, 27).
We are not aware of any published studies with the 
same size population and as detailed in radiographic 
measurements and patient demographic data as our 
study. However, our study had several limitations. 
This was a retrospective study based on patient record 
data of three university hospitals. Co-morbidity data 
were not included. Mean follow-up of our study was 
quite short, 4.3 years in the THA group and 5.1 years in 
the HRA group. Previously, it has been shown that a 
longer follow-up will reveal more problems related to 
MoM bearings, so a longer follow-up is needed in the 
future to see how revision rates between the groups 
develop. Furthermore, the strict definition of ARMeD 
at the time of these revisions were made was not clear. 
We did not measure whole blood metal ion levels, nei-
ther did we take hip magnetic resonance images for 
this study; this might underestimate the amount of 
ARMeD as a reason for revision. We did not include to 
our study THAs head sizes <38 mm because the com-
plication profile of small head size THAs is different 
as well as survival rates are known to be poorer (28).
COnCLUSIOn
THAs have more intraoperative complications than 
HRAs. HRAs have higher mid-term revision rate than 
THAs; however, time to revision was longer. Reasons 
for a higher revision rate of the HRAs are female gen-
der and a different operation technique in HRAs com-
pared with THAs. The overall HR of HRAs was higher 
than that of THAs. Problems related to MoM bearings 
have evoked in recent years, and complications and 
revision rates are going to significantly increase with 
longer follow-up.
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APPEnDIX 1 
Names and types of total hip arthroplasty components used.
n (%)
Conventional total hip arthroplasty 3029 (78.5)
 Femur components
  Fit-and-fill type 2605 (86.0)
   Biomet Bi-Metric (Biomet, Warsaw, In, USA) 2278 (75.2)
   Synergy (Smith & nephew, Memphis, Tn, USA) 321 (10.6)
   Biomet Integral (Biomet, Warsaw, In, USA) 5 (0.2)
   Mitch Symax (Stryker, Mahwah, nJ, USA) 1 (0.0)
  Tapered 380 (12.5)
   Conserve Profemur TL (Wright Medical Technology, Arlington, Tn, USA) 187 (6.2)
   Metasul CLS (Zimmer, Warsaw, In, USA) 145 (4.8)
   M/L Taper (Zimmer, Warsaw, In, USA) 46 (1.5)
   Accolade (Stryker, Mahwah, nJ, USA) 2 (0.1)
  Other 44 (1.5)
   Biomet Reach (Biomet, Warsaw, In, USA) 31 (1.0)
   Biomet CDH (Biomet, Warsaw, In, USA) 6 (0.2)
   Metalic 5 (0.2)
   Biomet Balance (Biomet, Warsaw, In, USA) 1 (0.0)
   Biomet Head/neck (Biomet, Warsaw, In, USA) 1 (0.0)
  Acetabulum components
   Biomet ReCap (Biomet, Warsaw, In, USA) 1852 (61.1)
   Biomet M2a38 (Biomet, Warsaw, In, USA) 469 (15.5)
   BHR (Smith & nephew, Memphis, Tn, USA) 246 (8.1)
   Conserve (Wright Medical Technology, Arlington, Tn, USA) 188 (6.2)
   Durom Cup (Zimmer, Warsaw, In, USA) 184 (6.1)
   R3 (Smith & nephew, Memphis, Tn, USA) 75 (2.5)
   MMC Cup (Zimmer, Warsaw, In, USA) 6 (0.2)
   Metalic 5 (0.1)
   Mitch TRH (Stryker, Mahwah, nJ, USA) 3 (0.1)
   Morscher Cup (Sulzer/Zimmer gmbH, Winterthur, Switzerland) 1 (0.0)
Hip resurfacing arthroplasty 831 (21.5)
   BHR (Smith & nephew, Memphis, Tn, USA) 467 (56.2)
   Biomet ReCap (Biomet, Warsaw, In, USA) 157 (18.9)
   Conserve Plus (Wright Medical Technology, Arlington, Tn, USA) 120 (14.4)
   Cormet (Corin, Tampa, FL, USA) 44 (5.3)
   Durom (Zimmer, Warsaw, In, USA) 23 (2.8)
   ASR (DePuy Orthopaedics, Warsaw, In, USA) 20 (2.4)
Total 3860 (100)
